Cargando…
Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report
INTRODUCTION: Acquired pure red cell aplasia is a rare disorder, usually appearing secondary to various pathologic conditions such as thymoma, systemic autoimmune diseases or in the course of lymphomas. Conventional treatment consists of immunosuppression with corticosteroids, antithymocyte globulin...
Autores principales: | Anastasiadis, Athanasios, Margaritis, Dimitrios, Kotsianidis, Ioannis, Spanoudakis, Emmanouil, Christoforidou, Anna, Kostopoulos, Ioannis, Tsatalas, Constantinos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Cases Network Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769326/ https://www.ncbi.nlm.nih.gov/pubmed/19918496 http://dx.doi.org/10.4076/1757-1626-2-6913 |
Ejemplares similares
-
The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition
por: Spanoudakis, Emmanouil, et al.
Publicado: (2018) -
Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma
por: Spanoudakis, E, et al.
Publicado: (2016) -
Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia
por: Mahajan, S. A., et al.
Publicado: (2015) -
Splenic marginal zone lymphoma in Sweden 2000–2020: Increasing rituximab use and better survival in the elderly
por: Junlén, Henna‐Riikka, et al.
Publicado: (2023) -
High-Grade Transformation in a Splenic Marginal Zone Lymphoma with a Cerebral Manifestation
por: Gao, Xiaoning, et al.
Publicado: (2017)